CB
BMY icon

Chemical Bank’s Bristol-Myers Squibb BMY Stock Holding History

Chemical Bank’s Portfolio BMY Stock Details BMY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q2 		$1.51M Sell
33,243
-1,197
-3% -$55.8K 0.17% 134
2019
Q1 		$1.64M Sell
34,440
-400
-1% -$19.9K 0.19% 120
2018
Q4 		$1.81M Sell
34,840
-6,163
-15% -$331K 0.22% 103
2018
Q3 		$2.54M Buy
41,003
+2,579
+7% +$153K 0.26% 86
2018
Q2 		$2.13M Buy
38,424
+133
+0.3% +$7.18K 0.23% 99
2018
Q1 		$2.42M Sell
38,291
-1,611
-4% -$104K 0.26% 88
2017
Q4 		$2.45M Sell
39,902
-1,131
-3% -$70.7K 0.26% 88
2017
Q3 		$2.62M Sell
41,033
-17,165
-29% -$1M 0.29% 80
2017
Q2 		$3.24M Sell
58,198
-900
-2% -$49K 0.35% 68
2017
Q1 		$3.21M Sell
59,098
-3,983
-6% -$218K 0.36% 68
2016
Q4 		$3.69M Buy
63,081
+20,482
+48% +$1.12M 0.42% 59
2016
Q3 		$2.3M Sell
42,599
-3,074
-7% -$197K 0.31% 76
2016
Q2 		$3.36M Buy
45,673
+1,245
+3% +$88K 0.46% 52
2016
Q1 		$2.84M Buy
44,428
+716
+2% +$45.2K 0.4% 60
2015
Q4 		$3.01M Sell
43,712
-105
-0.2% -$6.94K 0.42% 58
2015
Q3 		$2.59M Buy
43,817
+240
+0.6% +$15.2K 0.37% 72
2015
Q2 		$2.9M Sell
43,577
-630
-1% -$41.5K 0.38% 67
2015
Q1 		$2.85M Hold
44,207
– – 0.37% 70
2014
Q4 		$2.61M Sell
44,207
-866
-2% -$48.8K 0.34% 73
2014
Q3 		$2.31M Buy
45,073
+365
+0.8% +$18.2K 0.4% 61
2014
Q2 		$2.17M Sell
44,708
-2,433
-5% -$120K 0.37% 63
2014
Q1 		$2.45M Buy
47,141
+25
+0.1% +$1.33K 0.44% 56
2013
Q4 		$2.5M Sell
47,116
-7,550
-14% -$385K 0.45% 52
2013
Q3 		$2.53M Sell
54,666
-1,598
-3% -$70.1K 0.49% 49
2013
Q2 		$2.51M Buy
+56,264
New +$2.44M 0.5% 51

Other funds holding BMY

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Chemical Bank's BMY Position: Q2 2019 in Review

Chemical Bank reduced its Bristol-Myers Squibb (BMY) stake by 3.5% in Q2 2019, selling an estimated $55.8K and leaving 33,243 shares worth $1.51M. The position accounts for 0.17% of the portfolio, ranked #134.

Chemical Bank first reported a position in BMY in Q2 2013 and has held it in 25 quarters since. The position peaked at $3.69M in Q4 2016. 1,777 funds tracked by Wall St. Rank hold BMY as of Q2 2019.

  • Chemical Bank held 33,243 shares of Bristol-Myers Squibb worth $1.51M as of Q2 2019.
  • Chemical Bank sold 1,197 Bristol-Myers Squibb shares in Q2 2019, an estimated $55.8K.
  • Bristol-Myers Squibb made up 0.17% of Chemical Bank's portfolio in Q2 2019, its #134 holding.
  • Chemical Bank first reported a position in Bristol-Myers Squibb in Q2 2013 and has held it in 25 quarters since.
  • Chemical Bank's Bristol-Myers Squibb position peaked at $3.69M in Q4 2016.
  • 1,777 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2019.

Based on Chemical Bank's 13F filing for Q2 2019, filed 25 Jul 2019.